2020
DOI: 10.1186/s12955-020-01631-6
|View full text |Cite
|
Sign up to set email alerts
|

Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis

Abstract: Background The minimum clinical important differences (MCIDs) of resilience instruments in patients with cancer have not been comprehensively described. This study was designed to evaluate MCIDs of 10-item and 25-item resilience scales specific to cancer (RS-SC-10 and RS-SC-25). Methods From June 2015 to December 2018, RS-SCs were longitudinally measured in 765 patients with different cancer diagnoses at baseline (T0) and 3 months later (T1). The … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 42 publications
(46 reference statements)
1
12
0
Order By: Relevance
“…The Urdu versions of both the EORTC QLQ-C30 and QLQ-BN20 tools also demonstrated acceptable construct validity, with the global quality of life domain showing significant positive correlations with resilience (r = 0.422), and significant negative correlations with depression (r = −0.541) and anxiety (r = −0.502). Previous studies have also reported similar positive correlations between QoL and resilience [ 34 , 35 ] and similar negative correlations between QoL and depression and anxiety in cancer patients [ 36 , 37 ]. In addition, the Hindi translation of the EORTC QLQ-BN20 has also demonstrated significant correlations with depression and anxiety as measured by HADS [ 38 ].…”
Section: Discussionsupporting
confidence: 63%
“…The Urdu versions of both the EORTC QLQ-C30 and QLQ-BN20 tools also demonstrated acceptable construct validity, with the global quality of life domain showing significant positive correlations with resilience (r = 0.422), and significant negative correlations with depression (r = −0.541) and anxiety (r = −0.502). Previous studies have also reported similar positive correlations between QoL and resilience [ 34 , 35 ] and similar negative correlations between QoL and depression and anxiety in cancer patients [ 36 , 37 ]. In addition, the Hindi translation of the EORTC QLQ-BN20 has also demonstrated significant correlations with depression and anxiety as measured by HADS [ 38 ].…”
Section: Discussionsupporting
confidence: 63%
“…This issue should be clarified in future studies. Finally, in order to facilitate the clinical application of this questionnaire, the minimum clinical important difference of the instrument should perhaps be further evaluated [44].…”
Section: Discussionmentioning
confidence: 99%
“…The Cronbach's α of RS-SC-10 is 0.86. The Minimum Clinical Important Difference for RS-SC-10 is 2 points [20]. RS-SC-25 and RS-SC-10 were attached in the Additional file 1: Table S1 and Additional file 2: Table S2.…”
Section: Instruments 10-item Resilience Scale Specific To Cancer (Rs-sc-10)mentioning
confidence: 99%